MiNK Therapeutics shared a post on LinkedIn:
“Yesterday at AACRIO25, we presented new translational insights highlighting the powerful synergy between MiNK’s allo-iNKT cells, checkpoint inhibitors, and chemotherapy in Gastric Cancer.
Read more about the data.”
